Canada (CA)

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Active repair of a dinuclear photocatalyst for visible-light-driven hydrogen production (2022) Pfeffer MG, Müller C, Kastl ETE, Mengele AK, Bagemihl B, Fauth SS, Habermehl J, et al. Journal article Carotid Ultrasound Boundary Study (CUBS): Technical considerations on an open multi-center analysis of computerized measurement systems for intima-media thickness measurement on common carotid artery longitudinal B-mode ultrasound scans (2022) Meiburger KM, Marzola F, Zahnd G, Faita F, Loizou CP, Laine N, Carvalho C, et al. Journal article Erratum: Lattice-plasmon-induced asymmetric transmission in two-dimensional chiral arrays (APL Photonics (2022) 7 (016105) DOI: 10.1063/5.0074849) (2022) Apurv Chaitanya N, Butt MAT, Reshef O, Boyd RW, Banzer P, De Leon I Journal article, Erratum Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: Phase IIIb LUCY final analysis (2022) Balmana J, Fasching P, Delaloge S, Park YH, Eisen A, Bourgeois H, Kemp Z, et al. Conference contribution Updated overall survival (OS) results from the first-line (1L) population in the phase III MONALEESA-3 trial of postmenopausal patients (PTS) with HR+/HER2-advanced breast cancer (ABC) treated with ribociclib (RIB) plus fulvestrant (FUL) (2022) Neven P, Fasching P, Chia S, Jerusalem G, De Laurentiis M, Im SA, Petrakova K, et al. Conference contribution Assessment of side effects (SEs) impacting quality of life (QoL) in patients (pts) undergoing treatment (tx) for advanced breast cancer (ABC) in clinical practice: A real-world (RW) multi-country survey (2022) Cardoso F, Rihani J, Aubel D, De Courcy J, Harmer V, Harbeck N, Casas A, et al. Conference contribution KEYNOTE-522: Neoadjuvant Pembrolizumab plus Chemotherapy vs Placebo plus Chemotherapy Followed by Adjuvant Pembrolizumab vs Placebo for Early-stage Triple Negative Breast Cancer (2022) Mcarthur H, Cortes J, Dent R, Pusztai L, Kuemmel S, Bergh J, Denkert C, et al. Conference contribution Neighborhood Greenspace and Socioeconomic Risk are Associated with Diabetes Risk at the Sub-neighborhood Scale: Results from the Prospective Urban and Rural Epidemiology (PURE) Study (2022) Walker B, Brinkmann S, Große T, Kremer D, Schuurman N, Hystad P, Rangarajan S, et al. Journal article, Original article Guest Editorial Special Issue on Next Generation Multiple Access-Part II (2022) Liu Y, Zhang S, Ding Z, Schober R, Al-Dhahir N, Hossain E, Shen X Journal article, Editorial A gamma-ray pulsar timing array constrains the nanohertz gravitational wave background (2022) Ajello M, Atwood WB, Baldini L, Ballet J, Barbiellini G, Bastieri D, Bellazzini R, et al. Journal article